7.5 Pharmacotherapy for Co-Occurring Psychiatric Conditions in Intellectual Disability and Autism Spectrum Disorder

Abstract

The goal of this session is to provide a review of what is known (and what is not known) about the pharmacological treatment of co-occurring psychiatric conditions in patients suffering from intellectual disability (ID) and autism spectrum disorder (ASD). Furthermore, medication treatment data on neurogenetic syndromes that are associated with ID/ASD will also be considered. The clinical relevance of the extant research data and evidence-based treatment approaches will be discussed.